IRIS
RE, CHIARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.019
NA - Nord America 964
AS - Asia 681
SA - Sud America 89
Continente sconosciuto - Info sul continente non disponibili 58
AF - Africa 14
Totale 2.825
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 892
RU - Federazione Russa 551
SG - Singapore 276
IT - Italia 215
CN - Cina 192
BR - Brasile 66
DE - Germania 64
VN - Vietnam 54
HK - Hong Kong 52
CA - Canada 41
GB - Regno Unito 41
BD - Bangladesh 31
FR - Francia 30
IN - India 30
SE - Svezia 28
FI - Finlandia 25
NL - Olanda 17
PL - Polonia 12
JP - Giappone 10
IQ - Iraq 8
MX - Messico 7
EC - Ecuador 6
ES - Italia 6
JM - Giamaica 6
KR - Corea 6
AR - Argentina 5
CR - Costa Rica 5
ZA - Sudafrica 5
CO - Colombia 4
GT - Guatemala 4
LT - Lituania 4
TN - Tunisia 4
UA - Ucraina 4
AT - Austria 3
BE - Belgio 3
ID - Indonesia 3
IE - Irlanda 3
MD - Moldavia 3
MY - Malesia 3
BG - Bulgaria 2
BO - Bolivia 2
CL - Cile 2
DK - Danimarca 2
EG - Egitto 2
ET - Etiopia 2
PH - Filippine 2
RO - Romania 2
TR - Turchia 2
TT - Trinidad e Tobago 2
UZ - Uzbekistan 2
AG - Antigua e Barbuda 1
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
CY - Cipro 1
DZ - Algeria 1
EE - Estonia 1
GP - Guadalupe 1
GY - Guiana 1
HN - Honduras 1
JO - Giordania 1
KG - Kirghizistan 1
LC - Santa Lucia 1
NI - Nicaragua 1
NP - Nepal 1
OM - Oman 1
PE - Perù 1
PK - Pakistan 1
PR - Porto Rico 1
PT - Portogallo 1
PY - Paraguay 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
VE - Venezuela 1
Totale 2.767
Salva come PNG Salva come JPEG
Città #
Singapore 167
Ashburn 141
Dallas 129
San Jose 80
Moscow 77
Milan 52
New York 50
Hong Kong 49
Beijing 43
Los Angeles 34
Boardman 30
Council Bluffs 30
Shanghai 29
Munich 28
Phoenix 24
Santa Clara 20
Ho Chi Minh City 19
Hefei 18
Turku 18
Rome 17
Lauterbourg 14
Hanoi 12
Montreal 12
Orem 12
Denver 10
Amsterdam 9
Frankfurt am Main 9
Naples 9
São Paulo 9
Warsaw 9
Bar Harbor 8
London 8
Manchester 8
Nuremberg 8
Helsinki 7
Mumbai 7
North Bergen 7
Tokyo 7
Brooklyn 6
Falkenstein 6
Pune 6
Turin 6
Bologna 5
Chicago 5
Houston 5
Hyderabad 5
Johannesburg 5
Lawrence 5
Poplar 5
Princeton 5
Seattle 5
Toronto 5
Bari 4
Buffalo 4
Chennai 4
Da Nang 4
Guangzhou 4
Guatemala City 4
Kingston 4
Las Vegas 4
Miano 4
Palermo 4
Querétaro 4
Rio de Janeiro 4
San Francisco 4
Washington 4
Acalanes Ridge 3
Atlanta 3
Barnet 3
Belo Horizonte 3
Brescia 3
Brussels 3
Bến Tre 3
Cagliari 3
Catania 3
Columbus 3
Dhaka 3
Dublin 3
Guayaquil 3
Haiphong 3
Kansas City 3
Miami 3
Providence 3
Pyeongtaek-si 3
San José 3
Shenzhen 3
Teramo 3
The Dalles 3
Venice 3
Wroclaw 3
Alajuela 2
Annapolis 2
Bakersfield 2
Birmingham 2
Biên Hòa 2
Boston 2
Cancello e Arnone 2
Canoas 2
Carpi 2
Cologne 2
Totale 1.442
Salva come PNG Salva come JPEG
Nome #
"Case of the month from San Raffaele Hospital, Milan, Italy: paraneoplastic presentation of small renal masses" 194
A comprehensive assessment of frailty status on surgical, functional and oncologic outcomes in patients treated with partial nephrectomy––A large, retrospective, single-center study 187
Neglected lymph nodal metastases in patients with renal cancer: when to extend the anatomical template of lymph node dissection during nephrectomy 152
Pulmonary lesion after surgery for renal cancer: progression or new primary? 151
How to Select the Optimal Candidates for Renal Mass Biopsy 144
Preoperative risk calculator for the probability of completing nephron sparing for kidney cancer 142
Centralization of care for rare genetic syndromes associated with cancer: improving outcomes and advancing research on VHL disease 141
Clinical, pathological and long-term oncologic outcomes of papillary type I vs. type II renal cell carcinoma 138
Long-term functional outcomes in patients undergoing radical nephrectomy for renal cell carcinoma and tumor thrombus 135
Use of 18F-fluoro-2-deoxy-d-glucose (18F-FDG) PET/CT for lymph node assessment before radical cystectomy in bladder cancer patients 135
Risks and benefits of partial nephrectomy performed with limited or with zero ischaemia time 132
Differential Prognostic Value of Extrarenal Involvement in Patients With Non-Metastatic Renal Cell Cancer 130
How to optimize the use of adjuvant pembrolizumab in renal cell carcinoma: which patients benefit the most? 128
Head-to-head comparison of all the prognostic models recommended by the European Association of Urology Guidelines to predict oncologic outcomes in patients with renal cell carcinoma 125
The effect of frailty on post-operative outcomes and health care expenditures in patients treated with partial nephrectomy 117
Parenchymal biopsy in the management of patients with renal cancer 117
A machine learning-based analysis for the definition of an optimal renal biopsy for kidney cancer 109
Influences of Age and Comorbidities on Indication for Partial Nephrectomy: A Systematic Review 108
Head-to-head comparison of nephrometry scores for partial nephrectomy: implications for clinical guidelines 93
First results of NURE-Combo: A phase 2 study of neoadjuvant nivolumab (NIVO) and nab-paclitaxel (ABX) followed by postsurgical adjuvant NIVO in patients (pts) with muscle-invasive bladder cancer (MIBC) 48
Identifying optimal candidates for active surveillance in low-grade intermediate-risk non-muscle invasive bladder cancer 30
Utility of fluoro-deoxy-glucose positron emission tomography (FDG-PET) to predict a pelvic lymph node involvement (LNI) in patients (pts) with muscle-invasive bladder cancer (MIBC) enrolled in neoadjuvant therapy trials 30
Comprehensive genomic profiling (CGP) of clinical T2-4N0M0 muscle-invasive bladder cancer (MIBC) treated with neoadjuvant pembrolizumab or cisplatinbased chemotherapy before radical cystectomy (RC) 27
The Impact of Second Opinion Expert Pathology Review in Patient Management at the Time of Transurethral Resection of the Bladder 24
First Results of NURE-Combo: A Phase II Study of Neoadjuvant Nivolumab and Nab-Paclitaxel, Followed by Postsurgical Adjuvant Nivolumab, for Muscle-Invasive Bladder Cancer 22
Positive surgical margins after partial nephrectomy across changing surgical eras: long-term oncological results from a tertiary referral center 15
Adjuvant pembrolizumab plus belzutifan versus placebo in clear cell renal cell carcinoma: a reconstructed survival data analysis of the KEYNOTE-564 and the LITESPARK-022 trials 15
Impact of Body Mass Index on Renal Function Impairment in Patients Treated for Renal Cell Carcinoma at High Risk of Recurrence: Key Implications for Systemic Therapy Eligibility 13
Removing Barriers to the Use of Systemic Agents for Patients with von Hippel-Lindau Disease 12
Prognostic Impact of Initial Management Strategies in Metachronous Oligometastatic Renal Cell Carcinoma: A Real-World Evidence 11
Totale 2.825
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.243
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.243
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20227 0 0 0 2 0 0 0 0 0 0 0 5
2022/202352 10 9 3 5 3 6 4 6 2 0 1 3
2023/2024186 11 8 12 12 9 35 0 46 0 8 10 35
2024/2025394 28 12 22 30 24 20 55 52 56 22 28 45
2025/20261.732 98 81 113 177 162 59 132 171 459 127 88 65
2026/2027453 50 66 112 225 0 0 0 0 0 0 0 0
Totale 2.825